ArticleCureus2025
A Case of Cerebral Venous Sinus Thrombosis Following Eltrombopag in Immune Thrombocytopenia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eltrombopag is a second-line treatment option for patients with immune thrombocytopenic purpura (ITP) who have persistent thrombocytopenia. Although generally considered safe, it has been associated with uncommon thromboembolic complications. We report an 18-year-old female with ITP who developed superior sagittal sinus thrombosis after starting eltrombopag. Eltrombopag was discontinued, and anticoagulation was initiated with subsequent clinical improvement. This case highlights a serious complication of eltrombopag therapy and underscores the need for vigilant monitoring of platelet counts, timely dose adjustment, and early recognition of thrombotic events in patients with ITP receiving thrombopoietin receptor agonists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.